| R01 | R01PA-18-037 | The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) | 9/8/2018 |
| R21 | PA-18-040 | The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional) | 9/8/2018 |
| R15 | PA-18-210 | The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional) | 9/8/2018 |
| R03 | PA-18-054 | The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) | 9/8/2018 |
| R44 | PAR-18-108 | NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) | 9/6/2019 |
| R01 | PA-18-273 | Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional) | 1/8/2020 |
| R21 | PA-18-272 | Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21 Clinical Trial Optional) | 1/8/2020 |
| R21 | RFA-MD-20-005 | Methods and Measurement in Research with Sexual and Gender Minority Populations (R21 Clinical Trials Not Allowed) | 3/14/2020 |
| R01 | PAS-18-557 | Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional) | 5/8/2020 |
| R21 | PAR-19-326 | Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) | 11/13/2020 |
| R01 | PAR-18-747 | Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional) | 11/14/2020 |
| R21 | PAR-18-745 | Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional) | 11/14/2020 |
| R01 | PAR-20-237 | Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) | 12/2/2020 |
| NOSI | NOT-MD-20-022 | Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations | 12/30/2020 |
| NOSI | NOT-MH-20-053 | Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 | 12/30/2020 |
| R01 | PA-18-729 | Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) | 1/8/2021 |
| R21 | PA-18-728 | Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) | 1/8/2021 |
| R01 | PAR-18-324 | Testing Interventions for Health-Enhancing Physical Activity (Clinical Trial Optional) | 1/8/2021 |
| R01 | PA-18-651 | Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional) | 1/8/2021 |
| R21 | PA-18-652 | Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed) | 1/8/2021 |
| R34 | PA-18-653 | Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional) | 1/8/2021 |
| R01 | PAR-17-491 | Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional) | 1/8/2021 |
| R21 | PAR-17-490 | Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional) | 1/8/2021 |
| R01 | RFA-MD-21-002 | Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) | 1/16/2021 |
| R01 | PAR-20-243 | Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) | 3/3/2021 |
| R01 | PAR-20-243 | Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) | 3/3/2021 |
| R01 | PAR-19-018 | Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) | 3/5/2021 |
| R21 | PAR-19-019 | Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) | 3/5/2021 |
| R01 | PAR-19-384 | Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) | 3/18/2021 |
| R01 | PAR-19-373 | Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) | 3/18/2021 |
| R01 | PAR-19-209 | Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) | 5/7/2021 |
| R01 | PA-18-722 | Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) | 5/8/2021 |
| R21 | PA-18-723 | Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) | 5/8/2021 |
| R36 | PAR-18-894 | Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) | 5/8/2021 |
| R01 | PAR-18-847 | Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) | 6/16/2021 |
| R01 | PAR-18-847 | Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) | 6/16/2021 |
| R21 | PAR-18-848 | Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) | 6/26/2021 |
| S06 | PAR-20-125 | Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional) | 7/21/2021 |
| D43 | PAR-19-283 | Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) | 8/21/2021 |
| R41 | PA-18-927 | Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional) | 9/6/2021 |
| R43 | PA-18-928 | Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional) | 9/6/2021 |
| R01 | PAR-19-162 | Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) | 9/8/2021 |
| R21 | PAR-19-163 | Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) | 9/8/2021 |
| R01 | PA-19-042 | Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) | 9/8/2021 |
| R21 | PA-19-050 | Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) | 9/8/2021 |
| R01 | PAR-18-929 | High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) | 9/8/2021 |
| R01 | PAR-19-070 | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) | 11/13/2021 |
| R21 | PAR-19-071 | Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) | 11/13/2021 |
| R01 | RFA-DA-22-017 | PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) | 11/13/2021 |
| R01 | RFA-OD-19-029 | The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) | 11/27/2021 |
| U54 | RFA-OD-21-010 | Advancing Gender Inclusive Excellence (AGIE) – Coordinating Center (U54 - Clinical Trial Not Allowed) | 12/1/2021 |
| R01 | PAR-19-093 | Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) | 12/5/2021 |
| R01 | RFA-AI-21-058 | American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) | 12/10/2021 |
| U01 | RFA-CA-21-063 | A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) | 12/11/2021 |
| R01 | RFA-CA-20-046 | Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) | 12/15/2021 |
| R34 | RFA-AA-21-017 | HIV Prevention and Alcohol (R34 Clinical Trials Optional) | 12/17/2021 |
| R01 | RFA-AA-21-016 | HIV Prevention and Alcohol (R01 Clinical Trials Optional) | 12/17/2021 |
| U24 | RFA-CA-21-045 | Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required) | 12/29/2021 |
| UG1 | RFA-CA-21-046 | Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) | 12/29/2021 |
| UG1 | RFA-CA-21-047 | Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) | 12/29/2021 |
| R01 | RFA-MH-22-105 | Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) | 1/7/2022 |
| R01 | RFA-MH-22-106 | Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) | 1/7/2022 |
| R01 | PA-18-932 | Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) | 1/8/2022 |
| R15 | PAR-19-135 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) | 1/8/2022 |
| R15 | PAR-19-134 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) | 1/8/2022 |
| R01 | PA-18-932 | Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) | 1/8/2022 |
| R01 | RFA-MD-22-001 | Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) | 1/15/2022 |
| P50 | PAR-20-286 | Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) | 1/27/2022 |
| U24 | RFA-DA-22-033 | Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) | 2/18/2022 |
| R34 | RFA-MH-22-125 | Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) | 2/19/2022 |
| U01 | PAR-20-118 | National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) | 3/26/2022 |
| U19 | PAR-20-119 | National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) | 3/26/2022 |
| U24 | RFA-CA-22-014 | Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed) | 3/29/2022 |
| UM2 | RFA-HD-23-020 | Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional) | 4/1/2022 |
| UM2 | RFA-HD-23-021 | Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) | 4/1/2022 |
| R01 | PAR-20-088 | Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) | 4/2/2022 |
| R21 | PAR-20-081 | Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) | 4/2/2022 |
| R43/R44 | RFA-MD-22-004 | Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) | 4/5/2022 |
| R41/R42 | RFA-MD-22-003 | Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) | 4/5/2022 |
| R01 | RFA-NR-22-001 | Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | 4/8/2022 |
| R01 | RFA-NR-22-002 | Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | 4/8/2022 |
| R01 | RFA-NR-22-003 | Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | 4/8/2022 |
| U01 | RFA-OD-22-006 | Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) | 5/3/2022 |
| U01 | RFA-OD-22-005 | Emergency Awards: RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) | 5/3/2022 |
| R01 | PAR-19-236 | Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) | 5/8/2022 |
| R01 | RFA-MH-22-170 | Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) | 5/11/2022 |
| R21 | RFA-MH-22-171 | Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) | 5/11/2022 |
| U01 | RFA-RM-21-022 | Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional) | 5/24/2022 |
| R25 | PAR-20-080 | NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) | 5/26/2022 |
| R25 | RFA-LM-22-001 | Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed) | 6/1/2022 |
| R01 | RFA-MH-21-110 | Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) | 6/16/2022 |
| R25 | RFA-DK-22-004 | NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed) | 6/22/2022 |
| Notice | NOT-MD-22-015 | Administrative Supplements to Support "All of US" and Health Disparities-Related Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) | 6/28/2022 |
| Notice | NOT-PM-22-002 | Administrative Supplements to Advance Precision Medicine Using the All of Us Research Program’s Data | 7/6/2022 |
| R01 | PAR-20-079 | Surgical Disparities Research (R01 - Clinical Trial Optional) | 7/6/2022 |
| U54 | RFA-RM-22-008 | NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) | 7/13/2022 |
| U24 | PAR-20-048 | Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands (U24 – Clinical Trial Not Allowed) | 7/16/2022 |
| Notice | NOT-OD-22-125 | IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity | 7/17/2022 |
| Notice | NOT-MD-22-021 | Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborative HIV/AIDS Research at NIMHD-Funded Research Centers in Minority Institutions (RCMI) | 8/1/2022 |
| Notice | NOT-OD-22-159 | Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) | 8/2/2022 |
| Notice | NOT-MD-22-022 | Notice of Special Interest (NOSI): Administrative Supplements to Support Research on Preventive Interventions with Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) | 8/1/2022 |
| U24 | RFA-DA-23-052 | Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) | 8/11/2022 |
| R01 | RFA-MD-22-009 | Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) | 8/16/2022 |
| UG3 | PAR-20-092 | Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) | 9/2/2022 |
| R01 | PAR-19-297 | Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) | 9/8/2022 |
| R01 | PAR-19-368 | Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) | 9/8/2022 |
| U2C | RFA-DK-22-001 | Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed) | 10/27/2022 |
| R01 | RFA-MH-22-200 | Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed) | 10/19/2022 |
| R01 | RFA-AG-23-024 | Policy and Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) | 10/20/2022 |
| U24 | RFA-AG-23-027 | Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional) | 10/22/2022 |
| P30 | RFA-AG-23-025 | Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional) | 10/22/2022 |
| P30 | RFA-AG-23-026 | Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional) | 10/22/2022 |
| U54 | RFA-CA-22-019 | Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional) | 11/9/2022 |
| R01 | PAR-19-372 | Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) | 11/9/2022 |
| R01 | PAR-19-372 | Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) | 11/9/2022 |
| R01 | RFA-MH-22-191 | Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R24 Clinical Trial Not Allowed) | 11/19/2022 |
| R01 | RFA-MH-22-190 | Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required) | 11/19/2022 |
| R01 | PAR-21-344 | Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) | 12/21/2022 |
| U54 | PAR-22-249 | Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) | 1/7/2023 |
| Notice | NOT-MD-22-006 | Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities | 1/8/2023 |
| R01 | PAR-21-081 | Addressing Health Disparities Among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) | 1/8/2023 |
| R01 | PAR-21-080 | Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) | 1/8/2023 |
| R01 | PA-20-144 | Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) | 1/8/2023 |
| R21 | PA-20-145 | Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) | 1/8/2023 |
| R34 | PA-20-141 | Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) | 1/8/2023 |
| Notice | NOT-OD-22-031 | Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) | 2/1/2023 |
| Notice | NOT-OD-23-018 | Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) | 2/17/2023 |
| Notice | NOT-OD-23-002 | Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship | 2/18/2023 |
| Notice | NOT-OD-23-041 | Research Supplements to Promote Data Science Workforce Diversity to Reveal Scientific Insights of COVID-19 Testing Technologies (Admin Supp Clinical Trial Not Allowed) | 2/20/2023 |
| Notice | NOT-OD-23-029 | Research on Gender Measurement (Admin Supp Clinical Trial Optional) | 3/1/2023 |
| R03 | RFA-PM-23-002 | Small Grants to Enhance the Use of the All of Us Research Program’s Data (R03 Clinical Trial Not Allowed) | 3/2/2023 |
| K18 | PAR-23-107 | Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) | 3/18/2023 |
| K18 | PAR-23-108 | Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed) | 3/18/2023 |
| R21 | RFA-PM-23-001 | Enhancing the Use of the All of Us Research Program’s Data (R21 Clinical Trial Not Allowed) | 3/20/2023 |
| R01 | PAR-20-310 | Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) | 3/28/2023 |
| Notice | NOT-CA-23-032 | Notice of Special Interest (NOSI): Administrative Supplements to Initiate or Augment Outreach to and Inclusion of Sexual and Gender Minority (SGM) Populations | 4/2/2023 |
| R01 | RFA-MD-23-008 | Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) | 4/4/2023 |
| R01 | RFA-MD-23-007 | Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) | 4/4/2023 |
| R01 | RFA-NR-23-002 | Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional) | 5/2/2023 |
| R01 | RFA-NR-23-003 | Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) | 5/2/2023 |
| R01 | RFA-NR-23-004 | Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required) | 5/2/2023 |
| R21 | PAR-20-150 | NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) | 5/8/2023 |
| P20 | RFA-CA-23-038 | Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed) | 7/1/2023 |
| R01 | PAR-20-254 | Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | 7/20/2023 |
| R01 | RFA-DC-23-001 | NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) | 8/5/2023 |
| R01 | RFA-MD-23-004 | Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional) | 8/10/2023 |
| R01 | PAR-20-273 | New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) | 8/12/2023 |
| Notice | NOT-DK-22-003 | NIDDK Encourages Research on Sex/Gender Differences, Sexual and Gender Minority-Related Research and Race/Ethnic Diversity | N/A |
| Notice | NOT-MD-23-016 | Notice of Special Interest (NOSI): Administrative Supplements to support research by Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentors at NIMHD-Funded Research Centers in Minority Institutions (RCMI) | 9/1/2023 |
| R44 | RFA-MD-23-003 | Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) | 9/7/2023 |
| R42 | RFA-MD-23-002 | Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) | 9/7/2023 |
| R01 | PA-20-172 | Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) | 9/8/2023 |
| R01 | PAR-20-302 | Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) | 9/8/2023 |
| R01 | PAR-20-180 | Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) | 9/8/2023 |
| R01 | PA-20-172 | Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) | 9/8/2023 |
| R25 | RFA-OD-22-015
| Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) | 9/8/2023 |
| P30 | PAR-20-308 | AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) | 9/14/2023 |
| P30 | PAR-20-307 | Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) | 9/14/2023 |
| R01 | PAR-21-269 | Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed) | 10/14/2023 |
| R01 | RFA-DK-22-038 | Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01—Clinical Trial Required) | 10/20/2023 |
| R01 | RFA-NS-24-024 | Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed) | 11/2/2023 |
| R25 | PAR-20-236 | Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) | 11/16/2023 |
| R01 | RFA-HD-24-007 | Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional) | 11/30/2023 |
| R01 | RFA-CA-22-056 | Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) | 12/16/2023 |
| R21 | RFA-CA-22-057 | Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed) | 12/16/2023 |
| U01 | PAR-21-348 | The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) | 12/16/2023 |
| R01 | RFA-CA-22-050 | NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) | 2/7/2024 |
| U24 | RFA-ES-22-001 | Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) | 2/14/2024 |
| R01 | RFA-DA-22-040 | High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) | 2/16/2024 |
| Notice | NOT-OD-24-001 | Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship | 2/17/2024 |
| R01 | RFA-MH-25-126 | Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) | 2/21/2024 |
| R01 | RFA-EB-21-001 | Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) | 5/3/2024 |
| R34 | PA-21-205 | Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) | 5/8/2024 |
| R01 | PAR-22-072 | Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) | 5/8/2024 |
| Notice | NOT-AT-22-004 | Dissemination and Implementation Research to Advance Mental, Emotional, and Behavioral Health Preventive Interventions in School Settings | 6/5/2024 |
| R01 | PAR-23-092 | Effectiveness of Implementing Sustainable Evidence-Based Mental Health Practices in Low-Resource Settings to Achieve Mental Health Equity for Traditionally Underserved Populations (R01 Clinical Trial Optional) | 6/6/2024 |
| R01 | PAR-23-095 | Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) | 6/6/2024 |
| Notice | NOT-OD-21-100 | Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health | 6/8/2024 |
| R01 | PAR-21-349 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) | 6/22/2024 |
| R01 | PAR-21-350 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) | 6/22/2024 |
| R01 | PAR-21-352 | Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) | 6/22/2024 |
| R25 | RFA-NR-24-002 | Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed) | 7/2/2024 |
| UG3 | PAR-24-053 | Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required) | 8/6/2024 |
| U54 | RFA-OD-22-014
| Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
| 8/16/2024
|
| Notice | NOT-HD-23-001 | Notice of Special Interest (NOSI): Mortality of Adolescents, Young Adults, and Other NICHD Priority Populations in the United States | 9/8/2024 |
| R01 | PAR-22-092 | Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) | 9/8/2024 |
| R01 | PA-21-232 | Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) | 9/8/2024 |
| R01 | PAR-21-275 | The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) | 9/8/2024 |
| K08 | PAR-21-299 | NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) | 9/8/2024 |
| K08 | PAR-21-300 | NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) | 9/8/2024 |
| K22 | PAR-21-301 | NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) | 9/8/2024 |
| K22 | PAR-21-302 | NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) | 9/8/2024 |
| R36 | PAR-21-325 | Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) | 9/8/2024 |
